Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison A Williams

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurobiology of Disease|March 27, 2016
MECP2 impairs neuronal structure by regulating KIBRAAlison A Williams, Robin White, Ashley Siniard, et al.
Plos One|July 22, 2016
Apoptotic Activity of MeCP2 Is Enhanced by C-Terminal Truncating MutationsAlison A Williams, Vera J Mehler, Christina Mueller, et al.
Journal of Neurochemistry|May 28, 2018
Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction networkJonathan D Lautz, Emily A Brown, Alison A Williams VanSchoiack, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2012
Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapineAlison A Williams, Wendy M Ingram, Sarah Levine, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurobiology of Disease|March 27, 2016
MECP2 impairs neuronal structure by regulating KIBRAAlison A Williams, Robin White, Ashley Siniard, et al.
Plos One|July 22, 2016
Apoptotic Activity of MeCP2 Is Enhanced by C-Terminal Truncating MutationsAlison A Williams, Vera J Mehler, Christina Mueller, et al.
Journal of Neurochemistry|May 28, 2018
Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction networkJonathan D Lautz, Emily A Brown, Alison A Williams VanSchoiack, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2012
Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapineAlison A Williams, Wendy M Ingram, Sarah Levine, et al.
Pageof 1